16 February 2009 - Ark Therapeutics Group today announces that the first Named Patient Supply for Cerepro has been approved by the French Medicines Control Agency (AFSSAPS) following a 'nominative' ATU application made by a neuro-surgeon in France.
The details can be read here.
No comments:
Post a Comment